This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sylvester, P. W. Articles by Meites, J. Search for Related Content PubMed PubMed Citation Articles by Sylvester, P. W. Articles by Meites, J.

Relationship of Hormones to Inhibition of Mammary Tumor Development by Underfeeding during the "Critical Period" after Carcinogen Administration¹

Department of Physiology, Neuroendocrine Research Laboratory, Michigan State University, East Lansing, Michigan 48824

Seven days prior to 7,12-dimethylbenz(a)anthracene (DMBA) administration, virgin 50-day-old female Sprague-Dawley rats were placed on a food-restricted diet and continued on this regimen until 30 days after DMBA injection. One day prior to and 7 days after DMBA administration, animals were given daily 0.1-ml s.c. injections of 0.9% NaCl solution (controls), haloperidol (HAL; 0.5 mg/kg) to increase prolactin secretion, growth hormone (GH; 0.5 mg/kg), estradiol benzoate (EB; 1 µg/rat), or a combination of HAL, EB, and GH. Drug and hormone treatments were terminated after 8 days, but underfeeding continued for 30 days after DMBA administration, after which time all animals were placed on ad libitum feeding for the remainder of the 26-week experiment.

Food restriction for 7 days prior to and 30 days after DMBA administration resulted in a significant reduction in average tumor number and size by the end of the 26-week experiment. Treatment for 8 days with EB produced a significant increase in mammary tumor incidence despite underfeeding, whereas underfed rats given the combination of HAL, EB, and GH showed development and growth of mammary tumors equal to that of full-fed controls. Both EB and HAL significantly raised blood prolactin levels. GH alone had no apparent effect on mammary tumor incidence. These results indicate that reduced food intake during the "critical period" for induction of mammary tumors in rats by DMBA can produce inhibition of mammary tumor development throughout the 6-month period of this experiment and that administration of EB or the combination of EB, HAL, and GH for only 8 days can counteract the inhibition by underfeeding.

¹ Published with the approval of the Michigan Agricultural Experiment Station as Journal Article No. 9581.

² Aided in part by NIH Research Grants CA10771 from the National Cancer Institute, AM04784 from the National Institute of Metabolism, Arthritis and Digestive Diseases, and AG00416 from the National Institute on Aging.

Received 8/11/80. Accepted 1/12/81.

This article has been cited by other articles:

				H. J. Thompson, Z. Zhu, and W. Jiang Weight Control and Breast Cancer Prevention: Are the Effects of Reduced Energy Intake Equivalent to Those of Increased Energy Expenditure? J. Nutr., December 1, 2004; 134(12): 3407S - 3411S. [Abstract] [Full Text] [PDF]

				D. M.E Harvell, T. E. Strecker, B. Xie, K. L. Pennington, R. D. McComb, and J. D. Shull Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat Carcinogenesis, January 1, 2002; 23(1): 161 - 169. [Abstract] [Full Text] [PDF]

				E.-S. Han, T. R. Evans, S. Lee, and J. F. Nelson Food Restriction Differentially Affects Pituitary Hormone mRNAs throughout the Adult Life Span of Male F344 Rats J. Nutr., June 1, 2001; 131(6): 1687 - 1693. [Abstract] [Full Text]